GEN2-Recombinant COVID-19 Vaccine (CHO Cells)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameGEN2-Recombinant COVID-19 Vaccine (CHO Cells)
Drug Alias NameRecombinant COVID-19 Vaccine (CHO Cells)
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNational Vaccine and Serum Institute, China
China Registration ClassN/A

Develop Information

Active CompaniesNational Vaccine and Serum Institute, China
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A